Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots  by Collet, J.P. et al.
Biophysical Journal Volume 70 January 1996 500-510
Fibrinogen Dusart: Electron Microscopy of Molecules, Fibers and Clots,
and Viscoelastic Properties of Clots
Jean-Philippe Collet,** John L. Woodhead,* Jeannette Soria,* Claudine Soria,5 Manouchehr Mirshahi,t
Jacques P. Caen,11 and John W. Weisel*
*Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 USA;
and *Geffacs, Laboratoire Sainte-Marie, H6pital de l'Hotel Dieu, 75004 Paris; §Difema, Faculte de Medecine et de Pharmacie de Rouen,
Rouen; and '%nstitut des Vaisseaux et du Sang, H6pital Lariboisiere, 75010 Paris, France
ABSTRACT Ultrastructural perturbations resulting from defects in polymerization of fibrinogen Dusart, a congenital dysfi-
brinogenemia with the amino acid substitution Aa 554 arginine to cysteine, were investigated by a variety of electron
microscope studies. Polymerization of this mutant fibrinogen on addition of thrombin is impaired, producing clots with
decreased porosity and increased resistance to fibrinolysis, resulting in thrombotic complications in the family members with
this dysfibrinogenemia. Electron microscopy of rotary-shadowed individual molecules revealed that, in contrast to control
fibrinogen, most of the aC domains of fibrinogen or fibrin Dusart appeared to be free-swimming appendages that do not
exhibit intra- or intermolecular interactions either with each other or with the central domains. The location of albumin on the
aC domains was demonstrated by electron microscopy using anti-albumin antibodies. Electron microscopy of negatively
contrasted fibrin Dusart fibers indicated that they were less ordered than control fibers and had additional mass visible.
Electron microscopy of freeze-dried, unidirectionally shadowed fibers showed that they were twisted with a shorter pitch.
Scanning electron microscopy revealed that intact clots were made up of thin fibers with many branch points and very small
pore sizes. The viscoelastic properties of Dusart fibrin clots measured with a torsion pendulum indicated a marked increase
in stiffness consistent with the structural observations.
INTRODUCTION
Fibrinogen is made up of three pairs of nonidentical
polypeptide chains with a total molecular mass of 340 kDa.
All amino-terminal ends are linked together to form the
central nodule; the carboxyl-terminal ends of the B,B and 'y
chains comprise the end globular domains, which are con-
nected to the central region by three-chain, a-helical coiled
coils. The carboxyl-terminal ends of the Aa chains, known
as the aC domains, are folded back so that they interact with
each other and with the central region of fibrinogen (Vek-
lich et al., 1993; Gorkun et al., 1994). Clotting occurs when
the fibrinopeptides are cleaved from the central region of
the molecule, exposing binding sites that are complemen-
tary to sites that are always exposed at the ends of the
molecule. The fibrin monomers thus interact in a half-
staggered manner to form two-stranded protofibrils, which
then aggregate laterally to yield fibers. Fibers grow in size
and branch to produce a three-dimensional network that
functions to impede bleeding.
The organization of fibrin in a blood clot is a result of a
complex assembly process affected by the ratio of thrombin
to fibrinogen and other factors (Blomback et al., 1992;
Weisel and Nagaswami, 1992). The structure of the fibrin
clot is an important factor influencing the balance between
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clotting and fibrinolysis, thus affecting any tendency toward
thrombosis and cardiovascular disease. Aspects of the
mechanisms of assembly of the fibrin clot can be under-
stood through analysis of differences in the structures
formed by variant fibrinogens that have specific molecular
defects. Several variants have been associated with throm-
boembolism in vivo (Ebert, 1994), and the analysis of
differences in fibrin clot structures observed in such defects
may be crucial to our understanding of variations in sus-
ceptibility to thrombosis.
Dusart syndrome is a severe thrombotic disorder with a
high incidence of thromboembolism and abnormal fibrin
polymerization, related to a congenital dysfibrinogenemia
with the same name (Soria et al., 1983). The molecular
defect is located in the aC domain and consists of a sub-
stitution of cysteine for arginine at position 554 in the Aa
chain, with consequent binding of albumin (Koopman et al.,
1993; Siebenlist et al., 1993). This thrombotic disorder was
first attributed to an abnormal clot thrombolysis with re-
duced plasminogen binding to fibrin and defective plasmin-
ogen activation by tissue-type plasminogen activator (Soria
et al., 1983; Lijnen et al., 1984). Later studies showed that
the fibrin Dusart clot structure is very abnormal, consisting
of a rigid network with many thin fibers, resulting in greatly
decreased gel porosity (Collet et al., 1993; Koopman et al.,
1993; Siebenlist et al., 1993). Both the clot structure and the
rate of fibrinolysis were restored almost to normal by the
addition of dextran before clotting, which increases the fiber
diameter and pore size, thus providing evidence that the
increased rigidity and resistance to thrombolysis arise from
the abnormal architecture of the Dusart fibrin network (Col-
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let et al., 1993). Other studies have shown a correlation
between low gel porosity in plasma clots and premature
coronary heart disease (Fatah et al., 1992).
The structure of fibrin clots formed in vitro is largely
determined by the kinetics of polymerization (Weisel and
Nagaswami, 1992). The clotting time for fibrinogen Dusart
is longer than normal (Soria et al., 1983; Koopman et al.,
1993), and the rate and extent of lateral aggregation of
protofibrils is reduced (Soria et al., 1983; Collet et al., 1993;
Siebenlist et al., 1993). Lateral aggregation can be affected
by many factors, one of the most significant being intermo-
lecular interactions of the aC domains. Monoclonal anti-
bodies specific for particular regions of the aC domains
have dramatic effects on polymerization (Cierniewski and
Budzynski, 1992), as do aC fragments (Veklich et al., 1993)
or smaller portions of the aC domains (Lau, 1993). Differ-
ent preparations of fragment X, missing the aC domains,
also have impaired lateral aggregation (Mosesson et al.,
1967; Hasegawa and Sasaki, 1990; Gorkun et al., 1994).
Several other dysfibrinogenemias with amino acid substitu-
tions in the aC domains, including fibrinogen Caracas II
(Aa Ser-434 to N-glycosylated Asn (Maekawa et al.,
1991)), fibrinogen Marburg (missing Aa 461-611 (Koop-
man et al., 1992)), and fibrinogen Chapel Hill III (which has
the same molecular defect as fibrinogen Dusart (Wada and
Lord, 1994)), all appear to be defective in lateral aggrega-
tion.
It has been demonstrated that fibrin fibers are twisted, and
this twisting has been suggested as a mechanism for limi-
tation of the lateral growth of fibers (Weisel et al., 1987).
Therefore, a mutation affecting the molecules so that they
are less flexible, or that they polymerize with a different
amount of twist, could also contribute to differences in
lateral aggregation.
The present study investigates the effect of the Dusart
mutation on the morphology of the aC domains of fibrin-
ogen molecules, including the ultrastructural location of the
albumin within the aC domain. The distribution of the
abnormal Aa chains among the fibrinogen molecules was
also determined, because this mutation is heterozygous (So-
ria et al., 1983; Koopman et al., 1993). The detailed ultra-
structure of Dusart fibrin fibers was examined to ascertain
whether there were any differences in molecular packing
induced by the presence of the abnormal aC domains and to
determine the effect of the mutation on the degree of twist-
ing. The three-dimensional arrangement of the fibers within
the Dusart clot was visualized using scanning electron mi-
croscopy to determine qualitatively the network density
along with the extent of branching and average pore size.
Histograms were produced from measurements of fiber
bundle diameters, showing quantitatively the decreased lat-
eral aggregation. Because there are indications that the
mechanical properties of fibrin clots formed in vitro may be
correlated with the clinical symptoms of thrombosis and
thromboembolism (Fatah et al., 1992; Scrutton et al., 1994),
the viscoelastic properties of Dusart clots were also mea-
sured. The abnormalities observed at all levels of structure
indicate how the amino acid substitution and associated
albumin in fibrinogen Dusart affects fibrin polymerization,
and emphasize the significance of the contributions of the
aC domains to clot assembly and hence their effects on the
properties of the final gel network.
MATERIALS AND METHODS
Materials
Plasma was prepared from the blood of the subject and a normal individual,
as previously described (Collet et al., 1993). Fibrinogen was purified from
the plasma by standard methods (Blomback and Blomback, 1956). Dextran
(mol wt 40,000) was supplied by Assistance Publique (Paris, France). Goat
anti-human albumin polyclonal immunoglobulin G (IgG) antibody was
purchased from Bethyl Laboratories (Montgomery, Texas).
Transmission electron microscopy of individual
fibrinogen and fibrin molecules
Rotary-shadowed samples were prepared by spraying a dilute solution of
fibrinogen or fibrin molecules in a volatile buffer (0.05 M ammonium
formate at pH 7.4 or 0.125% (v/v) acetic acid at pH 3.5) and 30% (v/v)
glycerol onto freshly-cleaved mica and shadowing with tungsten in a
vacuum evaporator (Denton Vacuum Co., Cherry Hill, NJ) (Fowler and
Erickson, 1979; Weisel et al., 1985; Veklich et al., 1993). In some exper-
iments, the albumin attached to fibrinogen Dusart was labeled with anti-
human albumin antibodies before spraying and shadowing as described
previously for other studies with fibrinogen and antibodies (Veklich et al.,
1993). Samples at neutral pH were prepared by rapid dilution with con-
tinual stirring of concentrated protein solution with 0.05 M ammonium
formate at pH 7.4 and 30% (v/v) glycerol to a final concentration of -25
,ug/ml, and those at acid pH were prepared by dilution into 0.125% (v/v)
acetic acid at pH 3.5 with 30% (v/v) glycerol. These specimens were
examined in a Philips 400 electron microscope (Philips Electronic Instru-
ments Co., Mahwah, NJ), usually operating at 80 kV and a magnification
of 60,000X.
Electron microscopy of negatively contrasted
fibrin fibers
Samples were prepared from fibrinogen with added thrombin as described
previously (Weisel, 1986a). After the initiation of polymerization, aliquots
were taken at specific times and a drop of the mixture was immediately
placed on a grid covered by a carbon film and negatively stained with
1-2% (w/v) uranyl acetate. For observations of fine structural details with
this technique, it is important to use a very thin carbon film and to clean it
by glow discharge before application of the sample. In some cases, pre-
formed clots were applied to 300-mesh, glow-discharged carbon-coated
Formvar grids and then negatively contrasted with uranyl acetate. All of
these specimens were also examined in a Philips 400 electron microscope
generally operating at 80 kV and a magnification of 36,OOOX.
Electron microscopy of freeze-dried,
unidirectionally shadowed fibrin fibers
Samples were prepared by adding thrombin to fibrinogen as described
previously (Weisel et al., 1987) with the following modifications. Just as
the solution began to gel after the addition of thrombin to Dusart fibrino-
gen, the clot was dispersed with a Pasteur pipette and applied to a small
sheet of glass (microscope coverslip), which had been precoated with a thin
carbon film. The samples were washed with phosphate-buffered saline
buffer and stabilized by the addition of 1% uranyl acetate and rinsed with
distilled water and a solution of 30% ethanol. The samples were covered
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with another coverslip of the same size (without any carbon film) arranged
in a half-staggered manner, and then the drying process was started using
blotting paper. When only a very thin film of liquid remained, the upper
coverslip was removed and the sample was quickly frozen in liquid
nitrogen. The thin carbon film prevented squashing of the fibers onto the
surface of the glass.
Scanning electron microscopy of plasma clots
Scanning electron microscope experiments were carried out on clots that
were fixed, dehydrated, critical point dried and sputter-coated with gold,
and then observed using an Amray 1400 microscope (Amray Inc., Bedford,
MA)(Langer et al., 1988; Weisel and Nagaswami, 1992). Plasma clots
were made by recalcification of citrated plasma (one volume of 0.13 M
citrate for nine volumes of blood) prepared by centrifugation at 2500 x g
for 20 min. Plasma samples were recalcified with 0.5 M CaCl2 to a final
concentration of 25 mM. Thrombin was then added to a final concentration
of 0.2 IU/ml, and 0.1 ml of the mixture was used to fill pre-etched plastic
tubes in which one end was sealed with parafilm. This procedure, origi-
nally developed for permeation experiments (Collet et aL, 1993), provided
a mechanism for thorough rinsing of the clots. Clotting was allowed to
proceed to completion for 8 h in a moist atmosphere. Plasma clots were
rinsed by permeation of 0.15 M NaCl, 50 mM Tris-HCl, pH 7.4 buffer
through the gels after clotting but before fixation to remove all soluble
plasma proteins. Washed clots were then prepared for microscopy as
described above.
Measurement of viscoelastic properties of
plasma clots
Plasma was clotted under the conditions described above. Clots with a
volume of 0.115 ml were formed between 12 mm diameter glass coverslips
in a Plazek torsion pendulum similar to that described by Janmey and
others (Plazek et al., 1958; Gerth et al., 1974; Janmey, 1991). A momentary
impulse was applied to the pendulum at room temperature, causing free
oscillations with strains of less than a few percent. The dynamic storage
modulus, G', loss modulus, G", and loss tangent, tan 8, were calculated
from recordings of the oscillations (Janmey, 1991).
RESULTS
Electron microscopy of individual fibrinogen and
fibrin molecules
A previous study of fibrinogen Dusart molecules visualized
by electron microscopy using platinum-shadowed speci-
mens showed the presence of additional globular domains
(Siebenlist et al., 1993). However, a statistical analysis of
the localization of these nodules on the fibrinogen Dusart
and their distribution among molecules was not reported. In
the present study, fibrinogen Dusart molecules were rotary-
shadowed with tungsten before examination by electron
microscopy, a method that results in slightly enhanced res-
olution of the molecular substructure compared with plati-
num (Erickson and Fowler, 1983; Slayter, 1983; Williams,
1983) and allows individual aC domains of fibrinogen to be
consistently observed for statistical analysis (Veklich et al.,
1993). Some examples are shown in Fig. 1 A-D. Particular
attention was paid to the location of the aC domains, which
are associated with the central part of most control fibrin-
ogen molecules but appear as free nodules in fibrin mono-
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FIGURE 1 Electron microscopy of individual rotary-shadowed mol-
ecules. (A-D) Fibrinogen Dusart at pH 7.4. (A) Field of fibrinogen
Dusart molecules, showing examples with one or two extra large
nodules (some of which are indicated by arrows) and examples that are
trinodular with no apparent extra nodules. (B-D) Gallery of fibrinogen
Dusart molecules, again indicating the variety of appearances. (E-G)
Fibrinogen with IgG antibodies to human albumin bound. Each trinodu-
lar fibrinogen molecule has one or two three-lobed IgG molecules
(arrows) attached to nodules (representing albumin) adjacent to the
backbone of fibrinogen. (H) Field of fibrin Dusart monomer molecules.
Many molecules show one or more nodules adjacent to the rest of the
molecule; some fibrin molecules appear to be interacting via their aC
domains. Bar = 100 nm.
mer (Veklich et al., 1993; Gorkun et al., 1994). The results
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of observations of many molecules in several preparations
are summarized in Table 1; the results were similar in repeat
experiments and in classification by different individuals.
Individual molecules were classified according to our pre-
viously published scheme (Veklich et al., 1993; Gorkun et
al., 1994) as trinodular, trinodular with one additional large
nodule adjacent to the center of the molecule, or trinodular
with either one or two small additional nodules located
away from the backbone. At least 34% of fibrinogen Dusart
molecules displayed one or two additional nodules that were
often near the ends. About 8% of fibrinogen Dusart mole-
cules had a single large additional nodule, with the remain-
der (58%) being trinodular with no additional mass visible.
In contrast, 79% of control fibrinogen molecules were tri-
nodular with no additional mass, 15% had a single large
additional nodule, and 6% had one or two smaller additional
nodules.
Because it has been demonstrated that fibrinogen
Dusart has albumin attached via a disulfide bond to
cysteine 554 (Koopman et al., 1993; Siebenlist et al.,
1993), we used an anti-human albumin antibody to lo-
calize the albumin by electron microscopy of individual
molecules. The protein concentrations were dilute
enough that it was unlikely that an antibody could lie near
a fibrinogen molecule by chance. Shadowed IgG mole-
cules appeared as three small lobes in a variable but often
roughly triangular configuration. Antibodies were seen
binding to the additional nodules that were located near
the molecules but not directly in contact with the back-
bone (Fig. 1, E-G). There were one or two antibody
molecules bound per fibrinogen, consistent with the pres-
ence of an albumin on at least one of the two aC
domains.
Fibrin monomer was prepared from fibrinogen Dusart
and examined by electron microscopy. At pH 3.5, 79% of
TABLE 1 Shapes observed for Dusart fibrinogen and fibrin
under various conditions
Percentage of Molecules with the
Appearance
No. molecules *.
Sample examined 0- *+
Dusart fibrinogen,
pH 7.4 343 58 8 34
Control fibrinogen,
pH 7.4 409 79 15 6
Dusart fibrinogen,
pH3.5 346 16 11 73
Control fibrinogen,
pH 3.5* 134 16 0 84
Dusart fibrin,
pH 3.5 114 12 9 79
Control fibrin,
pH 3.5* 378 13 4 83
Dusart fibrin,
pH 7.4 319 17 37 46
Control fibrin,
pH 7.4* 344 22 71 7
*Data from Veklich et al. (1993) for comparison.
the molecules had one or more small additional nodules,
often near the molecular ends (Table 1). About 9% of
molecules displayed a single large additional nodule, and
12% were simply trinodular with no other visible mass. As
expected, results with fibrinogen Dusart at pH 3.5 were
similar with 73% of molecules having one or two small
additional nodules, 11% with one large additional nodule,
and 16% being simply trinodular. Both of these experiments
at acidic pH are controls, inasmuch as that the aC domains
of normal fibrinogen are mostly dissociated from each other
under these conditions (Table 1) (Veklich et al., 1993).
Fibrin Dusart monomer was brought to neutral pH and
quickly prepared for electron microscopy so that most
molecules had not yet started to polymerize. Here 17% of
molecules were simple trinodular structures, whereas
37% had a single large additional nodule and 46% had
one or two small additional nodules (Table 1; Fig. 1 H).
In contrast, normal fibrin monomers at neutral pH were
22% simple trinodular structures, whereas 71% had a
single large additional nodule and 7% had one or two
small additional nodules (Veklich et al., 1993).
Fiber substructure as determined by electron
microscopy of negatively contrasted and freeze-
dried unidirectionally shadowed specimens
The molecular packing in fibrin fibers was examined by elec-
tron microscopy of negatively contrasted fibers. As observed
previously with samples prepared by other methods (Collet et
al., 1993; Siebenlist et al., 1993), fibrin Dusart fibers were very
thin. Because the exclusion of stain by protein is directly
related to the brightness of the striations, analysis of the fibrin
band pattern can reveal aspects of the protein shape and mo-
lecular packing. Control fibrin fibers have a characteristic band
pattern with a repeat of 22.5 nm (Fig. 2 A) (Weisel, 1986a).
Some examples of the band pattern of fibrin fibers made by
addition of thrombin to fibrinogen Dusart are shown in Fig. 2,
B-F. The repeat was 22.5 nm, and the appearance of the band
FIGURE 2 Electron micrographs of negatively contrasted fibrin fibers.
(A) Control fibrin that has a distinctive band pattern with a 22.5 nm repeat.
(B-F) Fibers made from fibrinogen Dusart. These fibers, which are ar-
ranged from better to less well ordered, have the same band pattern and
repeat but are less well ordered. Some of the bright, stain-excluding spots
probably arise from the attached albumin molecules. Bar = 100 nm.
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pattern was generally similar to that of control fibrin fibers, but
the Dusart fibers were nearly always much less ordered. The
edges of the fibers are commonly very rough compared with
control fibrin fibers. In addition, there are areas that show
bright, stain-excluding nodules, although the disorder in the
cross-striations makes it difficult to correlate these bright areas
with any particular band making up the striations. In some
cases (Fig. 2, E and F), longitudinal strands are visible, corre-
sponding to individual protofibrils making up the fibers.
Freeze-dried fibers, unidirectionally shadowed with plat-
inum, were prepared so that we could look at the surface
structure of the fibers. As expected, the fibers were very
thin. The surface of the fibers usually appears to be rough,
probably a result of the same structures that give the edges
of the negatively contrasted fibers a frayed appearance.
These fibers sometimes had fine striations at a slight angle
to the longitudinal axis of the fiber (Fig. 3), indicating that
the fibers were made up of protofibrils that were twisted
around each other. However, these striations were difficult
to see because the fibers were thin and the distance over
which they could be observed, i.e., between two successive
branch points, was short. At each branch point, the surface
appearance changes because of the difference in direction of
shadowing. As a result, it was only possible to measure the
pitch of a few fibers. Nevertheless, it appears that the pitch
of the twisting may be shorter than that of control fibers.
The mean pitch was calculated from the measured angles of
the fine striations to be 770 ± 400 nm (mean ± SD), as
compared with 1930 ± 280 nm for control fibers (Weisel et
al., 1987).
Fibrin Dusart clot structure as observed by
scanning electron microscopy
Clots formed from Dusart plasma have been studied previ-
ously by electron microscopy of specimens prepared using
a freeze-etching technique (Collet et al., 1993). Although a
general picture of the alterations in clot structure induced by
the Dusart mutation was obtained by this technique, accu-
rate measurements of average fiber bundle diameters were
=N ~~~~~~~~~~~~4
FIGURE 3 Electron micrographs of unidirectionally shadowed fibrin
Dusart fibers. The fine striations at a slight angle to the fiber axis arise
because the fibers are made up of protofibrils twisted around each other.
Bar = 100 nm.
difficult because of limitations in the depth of etching.
Therefore, the clots in the present study were prepared by
critical point drying, sputter-coated with gold, and exam-
ined by scanning electron microscopy. For these experi-
ments, clots were made by addition of calcium and thrombin
to citrated plasma. Plasma clots from Dusart plasma are
shown in Fig. 4 A, and those from a control subject are in
Fig. 4 B. Dusart plasma clots were made up of thin fibers,
with closely spaced branch points to form a uniform mesh
with very small pores (Fig. 4 A). Average fiber bundle
diameters were 19 ± 8 nm (mean ± SD), compared with a
mean of 133 ± 38 nm for normal fibers from the control
plasma clots formed at the same time under the same
conditions. Histograms of fiber bundle diameters show that
the distribution of diameters is also much narrower for the
Dusart clots (Fig. 5 A) than for the control (Fig. 5 B). The
mean distance between branch points was estimated to be
290 ± 150 nm, in comparison with an average of 5000 +
1400 nm for control clots.
Plasma clots were also prepared in the presence of dex-
tran, which has been shown to produce a more normal
network structure from Dusart fibrin (Collet et al., 1993).
Clots formed from Dusart plasma in the presence of 15
mg/ml dextran 60 had average diameters of 81 ± 24 nm
(Fig. 4 C), whereas in the presence of 30 mg/ml dextran 60,
diameters were 120 ± 41 nm. Statistical analysis by the
unpaired t-test gave results of at least p < 0.99 for all of
these comparisons. Histograms of the fiber bundle diame-
ters in Dusart clots formed in the presence of 30 mg/ml
dextran (Fig. 5 D) are similar to those of control clots (Fig.
5 B), and those of Dusart clots with 15 mg/ml dextran (Fig.
5 C) are intermediate between those with the higher dextran
concentration and Dusart clots without dextran. Control
plasma clots are not much affected by the presence of
dextran (Fig. 4 D).
Viscoelastic properties of Dusart fibrin clots
It has been suggested that greater clot stiffness, i.e., resis-
tance to deformation, may increase the propensity of indi-
viduals to thrombotic disease (Fatah et al., 1992; Scrutton et
al., 1994). The stiffness and other viscoelastic properties of
clots can be measured directly by use of a torsion pendulum,
in which the recovery of a specimen from deformation
induced by an applied torsional stress is monitored. In one
mode of operation, the stress initiates a series of damped
harmonic oscillations, from which some of the viscoelastic
properties of the clot can be derived. Plasma clots from the
subject with fibrinogen Dusart were prepared by addition of
thrombin to recalcified plasma and application to the plates
of the torsion pendulum before clotting. Control clots were
formed from the plasma of a normal subject. Fibrinogen
concentrations were 2.3 mg/ml for Dusart plasma and 2.4
mg/ml for the control. The frequency of free oscillation was
-5 rad/s for Dusart clots and -2 rad/s for the control, and
results are summarized in Table 2. The measured storage
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FIGURE 4 Scanning electron micrographs of plasma fibnn clots. The magnification is the same for all images (bar = 3 ,um). (A) Clot made from
fibrinogen Dusart plasma. (B) Clot made from control plasma. (C) Clot made from Dusart plasma with 15 mg/ml dextran. (D) Clot made from control
plasma with 15 mg/ml dextran.
moduli (G') were 7240 ± 950 dyn/cm2 (mean ± SD) for
Dusart clots vs. 1220 ± 120 for control clots; the loss
moduli (G") were 570 ± 80 dyn/cm2 vs. 94 ± 16 for Dusart
and control clots, respectively. The loss tangents (tan 8 =
G"/G') were 0.079 and 0.077 for the Dusart and control
clots, respectively.
DISCUSSION
Localization of the aC domains and albumin on
individual fibrinogen and fibrin Dusart molecules
Because the molecular defect in fibrinogen Dusart has been
identified as Aa 554 (Arg -> Cys) (Koopman et al., 1993),
the aC domains were examined. Although the presence of
albumin on the aC domains of fibrinogen Dusart molecules
sometimes makes these nodules appear larger than normal,
there was insufficient resolution to enable the size of the
individual aC domains to be used as a criterion in the
classification scheme. Therefore, only the location of the
aC domains, as indicated by the presence or absence of
additional nodules, was used in the analysis of images of the
shadowed molecules (Veklich et al., 1993). If no additional
nodules were observed, it was assumed that the aC domains
were bound to the central region of the molecule, although
in a small percentage of cases they may be away from the
backbone but just not stand out sufficiently from the back-
ground. The observation of a single large additional nodule
adjacent to the central region was interpreted as indicating
that the two aC domains had been released from the tri-
nodular backbone, but remained bound to each other. Small
additional nodules located away from the backbone were
interpreted as being aC domains that were not associated
with either the central domain or the other aC domain.
Some examples of individual shadowed fibrinogen Dusart
molecules have been reported previously, but without any
statistical analysis (Siebenlist et al., 1993).
In characterizing images of individual molecules quanti-
tatively, we found that 42% (8% with one large extra nodule
plus 34% with one or two smaller extra nodules) of mole-
cules of fibrinogen Dusart displayed additional mass away
from the backbone of the molecule, compared with 21%
(15% with one large extra nodule plus 6% with one or two
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FIGURE 5 Histograms of fiber bundle diameters. (A) Clot from Dusart
plasma. (B) Control plasma clot. (C) Dusart plasma clot with 15 mg/ml of
dextran 60. (D) Dusart plasma clot with 30 mg/ml of dextran 60.
TABLE 2 Viscoelastic properties of fibrinogen dusart
plasma clots
Parameter Dusart Control
G', storage modulus (dyn/cm2) 7240 ± 950 1220 ± 120
G", loss modulus (dyn/cm2) 570 ± 80 94 ± 16
tan 6, loss tangent (G"/G') 0.079 0.077
small extra nodules) for control fibrinogen. In the present
study, the results obtained from quantitative characteriza-
tion of individual molecules suggest that there is a marked
reduction in the interactions of the aC domains of fibrino-
gen Dusart with the central nodule of the molecule, com-
pared with those of control fibrinogen. Furthermore, the low
percentage of molecules of fibrin monomer at neutral pH
with a single additional nodule near the central region of the
molecule (37% compared with 71% for control fibrin) sug-
gests that intramolecular interactions of the modified aC
domains are also adversely affected.
Because fibrinogen is heterozygous, half of the aC chains
should be normal. If the distribution of abnormal and nor-
mal chains is random, 25% of the molecules would be
completely normal, 25% would have two defective chains,
and the rest (50%) would have a single defect. In this case,
if the defective chains cannot interact with the central region
of fibrinogen, only 25% of the molecules would display a
normal trinodular structure with no additional mass, but a
much higher percentage (58%) of simple trinodular struc-
tures was observed in fibrinogen Dusart. Therefore, even
allowing for the fact that this value for the percentage of
molecules with no extra nodules may be slightly larger
because of the failure to detect some free aC domains, the
distribution of observed structures seems to be inconsistent
with the hypothesis of a random distribution of normal and
defective chains among the molecules.
On the other hand, if the Dusart molecules consist of
either two normal or two defective chains, then 50% of the
molecules should exhibit a simple trinodular structure,
which is much closer to the observed value of 58%. Thus,
our results are more consistent with the hypothesis that
these molecules consist of either two normal or two defec-
tive chains and not one of each. Such a segregation of
normal and abnormal polypeptide chains, so that apparently
there are no heterodimers, has also been observed for sev-
eral other dysfibrinogenemias (Galanakis et al., 1983; Ga-
lanakis and Hultin, 1990; Galanakis, 1991; Lee et al., 1991),
but heterodimers have been reported in some other cases
(Siebenlist et al., 1988; Galanakis et al., 1989).
It has previously been shown that fibrinogen Dusart has
albumin covalently bound to it (Koopman et al., 1993). At
least 90% of the albumin is bound to the aC domains
(Siebenlist et al., 1993). In our study, an antibody to albu-
min was used to localize spatially the albumin molecules on
the aC domains of fibrinogen Dusart. Because the bound
antibodies were generally located away from the trinodular
backbone of the fibrinogen molecule, it appears that the
albumin is bound to the globular portion of the aC domain.
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Fibrin Dusart Polymerization
Substructure of fibers from Dusart fibrin
The measured repeat and substructure of the band pattern of
fibers prepared by addition of thrombin to fibrinogen Dusart
is normal, although the fibers generally appear to be less
ordered. The pattern of striations of negatively contrasted
fibrin is a reflection of the protein density along the fiber,
and hence is directly related to the molecular structure and
packing. The fact that this pattern of striations is not af-
fected by the mutation indicates that the fundamental mo-
lecular packing is unchanged. On the other hand, the ob-
served disorder indicates that not all molecules or
protofibrils are in register. A reduced degree of order of the
fibers is probably to be expected, given that the band pattern
is not clearly visible in other thin fibers such as those
produced by control fibrinogen clotted with thrombin at
high salt concentration (Weisel, 1986b). However, the de-
crease in order with fibrinogen Dusart is so extreme that it
seems most likely that the albumin interferes with the in-
termolecular interactions, with the main effect being ob-
served in the lateral aggregation of protofibrils. Because
half of the chains will contain a bound albumin molecule,
there will be considerable additional mass that should show
up in the fibrin band pattern. If these albumin molecules
were always in the same location with respect to the glob-
ular domains of fibrin, there would be an increase in density
in the appropriate region(s) of the fibrin band pattern; this
region would become more effective at excluding stain and
would appear brighter. Regions with greater density were
observed in some fibers, although the locations of these
regions could not be correlated in a convincing way with
any particular cross-striations; this suggests that either the
aC domains, and consequently the albumin molecules, are
not arranged in an orderly manner in fibrin, or the localiza-
tion is not readily discernible because of the disorder of the
molecular packing in the fibers.
Electron microscopy of unidirectionally shadowed fibers
from fibrinogen Dusart demonstrated that these are twisted
structures. Like control fibers, they are made up of proto-
fibrils twisted around each other (Medved' et al., 1990). It
appears that normally this twisting may limit the extent of
lateral aggregation of fibers so that their diameters reach a
plateau (Weisel et al., 1987; Weisel, 1988). Protofibrils are
added to a growing fiber until the energy of binding from
the addition of a new protofibril is exceeded by the energy
required to stretch that protofibril because of the increasing
diameter. Experimentally, the pitch of the twist of fibrin
Dusart fibers was difficult to measure because the fibers are
so thin and the distance between branch points is very short.
However, it appears that the pitch may be somewhat smaller
than that of control fibers.
Because twisting appears to play a role in determining the
diameters of fibrin fibers (Weisel et al., 1987) and fibers
from fibrinogen Dusart are much thinner, any possible ef-
fects of this mutation on twisting should be considered. The
main determinant of the pitch of twisting of a protofibril,
complementary binding sites at the ends and the middle of
each fibrin molecule. The pitch will be shorter if the sites at
the ends of the molecule are farther off the longitudinal axis
of the molecule. It seems unlikely that a mutation in the
carboxyl-terminal Aa chain would perturb the locations of
these complementary binding sites, and it has been shown
that removal of the aC domains, which would probably not
affect the complementary binding sites, does appear to
correct the defect in this mutation (Siebenlist et al., 1993).
Thus, with this assumption, the protofibrils would have the
same pitch as usual. However, the observations of nega-
tively contrasted fibers demonstrating that the fibers are
disordered indicates that interactions between protofibrils
are not as regular as normal, probably because interactions
between them are weaker. Protofibril interactions could be
weaker because there are fewer aC-aC domain interactions,
because there is a mixture of normal and abnormal mole-
cules. The pitch of the fibers is more irregular, as indicated
by the larger standard deviation, but also appears to be
shorter, perhaps because weaker aC-aC interactions allow
an added protofibril, with a right-hand twist, to interact
preferentially with the next protofibril in the right-hand
direction, causing a decrease in pitch. Furthermore, it should
be noted that the longitudinal disorder in these fibers means
that protofibrils at the fiber periphery need not be stretched
as much, and hence interactions leading to greater twisting,
or shorter pitch, are less hindered.
Thus, it seems that the fibers are probably thinner pri-
marily because of weaker intermolecular interactions be-
tween aC domains, not because of an intrinsic limitation
arising from stretching of fibrin molecules. On the other
hand, the limitation on the pitch at the lower end (i.e., one
standard deviation below the mean, or --370 nm) could
arise from the limits to the flexibility of fibrin, given that the
calculated elongation for a fiber of 20 nm diameter would
be 1.014 (e = ((2lTrlp)2 + 1)'/2), which is about the same as
that previously determined as the limiting value of 1.013 for
the growth of control fibers (Weisel et al., 1987; Weisel,
1988).
The abnormal molecular and fiber structure of Dusart
fibrin may account for both the reported resistance to plas-
min and the defective activation of plasminogen to plasmin
by tissue-type plasminogen activator (t-PA), leading to the
hindrance to thrombolysis observed in Dusart clots. Plas-
minogen binds less to fibrin Dusart than to control fibrin
(Lijnen et al., 1984). The abnormal aC domains and the
extra mass of the albumin may play a critical role, inasmuch
as these changes could modify the interaction of plasmino-
gen with its binding site on fibrin (Weisel et al., 1994). On
the other hand, it may be that the observed changes in fiber
structure, such as thinner, less well-ordered fibers with a
shorter pitch, affect plasminogen binding. In either case,
anything that affects plasminogen binding could be impor-
tant, because this appears to be a limiting factor in fibrin-
olysis (Hoylaerts et al., 1982; McDonagh, 1994). These
results, demonstrating an increased resistance to fibrinolysis
and hence presumably of fibers as well, is the location of the
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by thin fibers, are also in agreement with experiments
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involving the effect of fibrin structure on the rate of fibrin-
olysis (Gabriel et al., 1992). These studies demonstrated that
the thickness of fibrin fibers determines the pattern of lysis;
namely, with thin fibers, there is a reduced rate of conver-
sion of plasminogen to plasmin by t-PA and a reduced rate
of plasmin cleavage; hence, clots made of thin fibers are
lysed more slowly than those made of thicker fibers. Thus,
the results of fibrinolysis of fibrin Dusart are consistent with
these other studies, although the exact mechanisms of re-
sistance to plasmin remain incompletely defined.
Structure and mechanical properties of fibrin
Dusart clots
Whole clots can be examined by scanning electron micros-
copy, and clots prepared by the methods described here are
probably better preserved than those prepared by other
techniques. Clots from fibrinogen Dusart are dramatically
different than control clots. It is immediately apparent that
the clots are made up of thin fibers with very short distances
between branch points; the fibers are very thin, 19 nm vs.
133 nm for control fiber diameters. Dextran, which has
previously been shown to modify normal fibrin polymer-
ization such that thicker fibers are formed (Dhall et al.,
1976; Carr and Gabriel, 1980; Blomback et al., 1992), also
increases the diameters of Dusart fibers such that histo-
grams of fiber bundle thickness are similar to those from
control plasma without dextran, although the molecular
mechanism involved is not known.
It seems that the Dusart fiber diameters are even thinner
than would be expected from loss of the intermolecular
interactions of the aC domains. However, this is not a
strong conclusion, because experiments involving polymer-
ization of various fragment X-like preparations missing the
carboxyl-terminal a chain, and other related experiments,
yield variable results depending on the experimental condi-
tions (Mosesson et al., 1967; Holm et al., 1985; Medved' et
al., 1985; Hasegawa and Sasaki, 1990; Maekawa et al.,
1991; Cierniewski and Budzynski, 1992; Koopman et al.,
1992; Gorkun et al., 1994). It is likely that the extra mass of
the albumin molecules covalently linked to the a chain
interferes with the kinetics of polymerization. Lateral ag-
gregation would be more affected than earlier steps because
of the accumulation of additional mass from many abnormal
molecules in the protofibrils. Evidence supporting this in-
terpretation comes from experiments involving the addition
of aC fragments to fibrin monomer (Veklich et al., 1993;
Gorkun et al., 1994). In these studies, where intermolecular
interaction via the aC domains is blocked by the aC frag-
ments, the decrease in final turbidity, which is indicative of
thin fibers, is much more striking than with fragment X
monomer, where the aC domains are merely missing.
The viscoelastic properties of the Dusart plasma clots
were strikingly different than those of the control with
respect to both the storage modulus (G') and the loss mod-
ulus (G"), suggesting that this dysfibrinogenemia may pro-
how fibrin structure relates to the mechanical properties of
a clot. G' for the Dusart clots, which is a measure of their
elastic properties or stiffness, was about six times higher
than that of the control clots, even though the fibrinogen
concentrations were similar in both of the plasma samples.
Although the mechanisms responsible for the elasticity of
fibrin clots are not entirely known (Ferry, 1988), in general,
an increase in G' could arise from an increase in the number
of branch points or an increase in the stiffness of the fibers
(Gerth et al., 1974; Janmey et al., 1991). Comparison of the
scanning electron microscope images of the clots from
Dusart and control plasmas (Fig. 4, A and B) shows a
dramatic increase in the number of branch points (nearly
20-fold) for the dysfibrinogenemic subject, which would be
expected to contribute to a large increase in the storage
modulus. However, this effect is probably partially offset by
a decrease in stiffness of the Dusart fibers, given that they
are both thinner and less ordered than those in control clots.
The very thin fibers making up fine clots formed from
purified fibrinogen at high pH and ionic strength, for ex-
ample, result in structures with lower G' values than those
of clots formed under physiological conditions with thicker
fibers (Gerth et al., 1974; Roberts et al., 1974; Nelb et al.,
1976).
In addition, the loss modulus (G"), which represents the
energy dissipated by nonelastic, viscous processes, was also
increased in Dusart plasma clots, even though its thinner
fibers would be expected to give rise to a smaller G"
(Roberts et al., 1973, 1974; Gerth et al., 1974; Nelb et al.,
1976). These experiments have also suggested that the vis-
cous processes represented by G" appear to arise primarily
from slippage between protofibrils in the fibers. Thus, the
greater G" for Dusart clots is consistent with the looser and
less ordered structure of the fibers that was observed in
negatively contrasted preparations (Fig. 2). On the other
hand, the loss tangent (tan 8 = G"/G'), which is a measure
of the energy dissipated by viscous processes relative to the
energy stored by elastic processes, is essentially the same
for both Dusart and control clots. This result is compatible
with the foregoing discussion, because it would be expected
that the thinner fibers of the Dusart clots would cause tan 8
to be lower than that of the control were it not for the
weaker interactions between protofibrils that would increase
G" relative to G'.
The dramatic increase in the stiffness of Dusart clots, as
indicated by G' and by the compaction coefficients mea-
sured previously (Collet et al., 1993), may be a contributing
factor to the tendency toward thrombosis and thromboem-
bolism in subjects with this dysfibrinogenemia. The en-
hanced resistance of Dusart clots to mechanical deformation
means that these clots are more likely to retain their form
under hydrostatic pressure and thus restrict blood flow.
Evidence to support this suggestion comes from a study in
which a correlation was established between the in vitro
formation of a tight, rigid gel network and a propensity
toward premature cardiovascular disease (Fatah et al.,
vide a good example for furthering our understanding of
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1992). Furthermore, one possible contributing factor toward
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fibrinogen as a cardiovascular risk factor is the logarithmic
increase in stiffness of plasma clots with increasing fibrin-
ogen concentration (Scrutton et al., 1994).
Mechanisms of abnormal polymerization of
fibrinogen Dusart
There is now considerable evidence (referenced in the In-
troduction) that the aC domains of fibrin are involved in
lateral aggregation. The aC domains are associated with
each other and with the central domain in both control
fibrinogen and fibrin monomer desA, but interact intermo-
lecularly in desAB fibrin (Veklich et al., 1993; Gorkun et
al., 1994). Since cleavage of the B fibrinopeptides usually
occurs after polymerization to form protofibrils, the aC
domains would then interact to bring protofibrils together,
i.e., to increase the diameter of fibers.
In these as well as previous studies (Collet et al., 1993;
Koopman et al., 1993; Siebenlist et al., 1993), the fibrinogen
Dusart mutation in the aC domain has been demonstrated to
have striking effects on the clot structure. The fibers are
greatly reduced in diameter, an effect that probably arises
because the altered aC domains do not interact with each
other in a normal way, as reported in the present study. It
should be noted that studies in which the aC domains were
cleaved from fibrinogen Dusart showed that the clot struc-
ture was closer to normal (Siebenlist et al., 1993). Alto-
gether, these results provide strong evidence on the impor-
tance of the aC domains in fibrin assembly.
The very short distance between branch points may be a
result of increased branching because of fewer aC-aC in-
teractions. However, increased branching also seems to be
correlated with the growth of thin fibers. A quantitative
study of clot structures under various conditions has dem-
onstrated that the distance between branch points decreases
with fiber diameter, so that clots made up of very thin fibers
will have a great many branch points (Baradet et al., 1995).
The high degree of branching in Dusart plasma clots
results in a greatly reduced average pore size, which is
consistent with the observation that the flow required to
transport proteins or other components of blood into a clot
or thrombus is greatly reduced (Collet et al., 1993). This
aspect of clot structure probably has a direct bearing on the
balance between clotting and fibrinolysis in the subjects
who carry this dysfibrinogenemia, providing an additional
contribution to their strong tendency toward thrombosis and
thromboembolism.
The Dusart syndrome may provide a model of thrombotic
disorders that could be a useful aid for the development of
new antithrombotic strategies, especially with the finding of
similar (although perhaps not so extreme) clots formed from
the plasma of patients who have had myocardial infarction
at an early age (Fatah et al., 1992). Modulation of the fibrin
gel architecture toward a coarser network could represent a
way to improved fibrinolytic therapy. The direct involve-
ment of the aC domains in lateral aggregation demonstrated
in earlier studies is dramatically reinforced by fibrinogen
Dusart, suggesting that this part of the fibrinogen molecule
may be an appropriate target for attempts to alter clot
structure to decrease thrombosis.
CONCLUSIONS
1) The aC domains of fibrinogen Dusart do not interact
intramolecularly with each other or with the central region
of the molecule, and the aC domains of Dusart fibrin do not
interact intermolecularly to promote lateral aggregation. 2)
The covalently linked albumin molecules are located on the
globular portion of the aC domain. 3) Fibrin fibers from this
mutant fibrinogen are much less ordered than control fibers
and are twisted structures with a pitch that appears to be
smaller than normal. 4) The fibers are much thinner than
those of control clots, as a result of the defective aC
domains and the extra mass from the bound albumin, both
of which affect the kinetics of lateral aggregation. 5) These
defective properties of fibrinogen and fibrin lead to the
formation of an extremely abnormal three-dimensional net-
work with much shorter distances between branch points,
resulting in clots with very small pores. 6) The viscoelastic
properties of Dusart clots indicate a dramatic increase in
stiffness, consistent with the observed structural differences.
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